Combating Counterfeit Pharmaceuticals Act of 2025 amends the Fentanyl Sanctions Act to address trafficking of copy-cat and counterfeit drugs and.
Combating Counterfeit Pharmaceuticals Act of 2025 amends the Fentanyl Sanctions Act to broaden its scope from opioids to all illicit drugs. It redefines terms such as "illicit drug" and "counterfeit drug," and modifies requirements for the Director of National Intelligence. The bill also introduces a waiver for access to prescription medications on the current drug shortage list. It includes technical and conforming amendments to various sections of the Act.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.